163 related articles for article (PubMed ID: 18281786)
1. Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis.
Yen MT; Wall VK
Ann Plast Surg; 2008 Jan; 60(1):6-9. PubMed ID: 18281786
[TBL] [Abstract][Full Text] [Related]
2. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
de Ru JA; Buwalda J
J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
Graboski CL; Gray DS; Burnham RS
Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
6. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
Gassner HG; Sherris DA
Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin reduces anal spasm but has no effect on pain after haemorrhoidectomy.
Singh B; Box B; Lindsey I; George B; Mortensen N; Cunningham C
Colorectal Dis; 2009 Feb; 11(2):203-7. PubMed ID: 18462246
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome.
Onguchi T; Takano Y; Dogru M; Ono M; Tsubota K
Am J Ophthalmol; 2004 Oct; 138(4):654-5. PubMed ID: 15488799
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.
Cohen BL; Rivera R; Barboglio P; Gousse A
J Urol; 2007 Mar; 177(3):1006-10; discussion 1010. PubMed ID: 17296397
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injection pain relief using a topical anesthetic skin refrigerant.
Engel SJ; Afifi AM; Zins JE
J Plast Reconstr Aesthet Surg; 2010 Sep; 63(9):1443-6. PubMed ID: 19716355
[TBL] [Abstract][Full Text] [Related]
12. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
13. Interaction of botulinum toxin type A with local anesthetic agents: an experimental study with rabbits.
Görgü M; Silistreli OK; Karantinaci B; Ayhan M; Ozdemirkiran T; Celebisoy M
Aesthetic Plast Surg; 2006; 30(1):59-64. PubMed ID: 16404653
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
16. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
[TBL] [Abstract][Full Text] [Related]
17. EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double-blind, placebo-controlled trial.
Kashkouli MB; Salimi S; Bakhtiari P; Parvaresh MM; Sanjari MS; Naseripour M
Ann Plast Surg; 2008 Apr; 60(4):353-6. PubMed ID: 18362558
[TBL] [Abstract][Full Text] [Related]
18. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
Monheit G; Carruthers A; Brandt F; Rand R
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S51-9. PubMed ID: 17241415
[TBL] [Abstract][Full Text] [Related]
20. Novel cutaneous uses for botulinum toxin type A.
Bansal C; Omlin KJ; Hayes CM; Rohrer TE
J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
